Back to MW MARSHALL WACE, LLP

VNDAVNDA
23 quarters

Position history for MWMARSHALL WACE, LLP's holdings in VANDA PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 1.2M shares of VNDA (VANDA PHARMACEUTICALS INC), worth $7.5M as of 2026-Q2. The position was increased (+105.7% shares). VNDA represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$7.5M

Current Shares

1.2M

Total Value Change

+$7.5M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+105.7%
$7.5M0.0%$6.12
44
2026-Q1
New
596,002
-
$4.1M0.0%$7.84
37
2025-Q4
Exited
0
-100.0%
$00.0%$7.03
0
2025-Q3
Increased
581,247
+23.2%
$2.9M0.0%$4.91
32
2025-Q2
Increased
471,720
+945.9%
$2.2M0.0%$4.78
42
2025-Q1
Decreased
45,100
-44.2%
$207,0090.0%$4.69
0
2024-Q4
New
80,800
-
$387,0320.0%$4.78
33
2024-Q3
Exited
0
-100.0%
$00.0%$4.67
0
2024-Q2
Decreased
24,504
-63.2%
$138,4480.0%$5.65
0
2024-Q1
Decreased
66,645
-64.5%
$273,9110.0%$4.11
0
2023-Q4
New
187,497
-
$791,2380.0%$4.22
34
2022-Q3
Exited
0
-100.0%
$00.0%$9.77
0
2022-Q2
Decreased
12,818
-23.1%
$140,0000.0%$10.85
0
2022-Q1
New
16,664
-
$189,0000.0%$11.38
31
2021-Q1
Exited
0
-100.0%
$00.0%$14.88
0
2020-Q4
Decreased
121,010
-56.0%
$1.6M0.0%$13.29
0
2020-Q3
Increased
274,854
+172.7%
$2.7M0.0%$9.51
42
2020-Q2
Decreased
100,793
-84.4%
$1.2M0.0%$11.22
0
2020-Q1
Increased
647,460
+40.2%
$6.7M0.1%$9.67
36
2019-Q4
Increased
461,691
+1.0%
$7.6M0.1%$16.40
28
2019-Q3
Increased
457,145
+793.4%
$6.1M0.0%$13.62
44
2019-Q2
Increased
51,170
+1827x
$721,0000.0%$14.09
40
2019-Q1
New
28
-
$00.0%$18.40
17

Other major holders of VNDA: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used